Skip to main content

Advertisement

Table 3 Subgroup analysis and meta regression of pooled HRs for OS in cancer patients with increased HOXA11-AS expression

From: Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors: a meta-analysis

Subgroup analysis No. of studies No. of patients Pooled HR (95% CI) Meta regression (p value) Heterogeneity
I2 p value
Region
 China 5 349 2.31 (1.29–4.13)   78.9% 0.001
 Other 3 971 1.90 (1.05–3.42) 0.677 76.5% 0.005
Sample size
 ≥ 100 2 879 1.69 (0.89–3.21)   76.8% 0.013
 < 100 6 441 2.37 (1.40–4.02) 0.469 78% < 0.001
Preoperative treatment
 No 5 436 2.28 (1.68–3.10)   0.4% 0.404
 Unclear 3 884 1.32 (0.99–1.76) 0.187 71.8% 0.014
NOS score
 ≥ 7 5 430 2.26 (1.67–2.98)   0 0.506
 < 7 3 890 1.77 (1.32–2.37) 0.238 74.1% 0.009